MAP3K7 and frontometaphyseal dysplasia 2: Crucially, MAP3K7 mutations in CSCFS are characterized by loss-of-function (LOF) effects, which contrasts mechanistically with the gain-of-function (GOF) variants that cause Frontometaphyseal Dysplasia Type 2 (FMD2) (7, 10).